Defense Health Agency SBIR Phase II
Supports United States defense health teams maturing validated medical technologies toward practical military use.
Defense Health Agency SBIR Phase II is the development stage of DHA's congressionally mandated Small Business Innovation Research program, open to Phase I awardees who have demonstrated scientific, technical, and commercial feasibility. DHA administers the program to mature military medical and health technologies through prototype development and validation, targeting eventual transition to DoD a…
Continuation of the firm's DHA SBIR Phase I technical effort, or Direct-to-Phase II for topics that explicitly opt in.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up